From Name:
From Email:
To Name:
To Email:

Optional Message:


Derma Sciences foot-wound drug shows promise

from Reuters

Derma Sciences Inc said foot ulcers in 85 percent of diabetic patients healed completely after being treated with its experimental drug at the end of a 24-week trial, improving its chances of licensing the drug to potential partners. Michael Higgins, a Rodman & Renshaw analyst, who has a "market outperform" rating on the stock, said he was most impressed by the drug's ability to heal wounds 13.5 week sooner than the placebo. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063